CLINICAL_TRIALS
trial_result
· 2020-08-11
Clinical Trial Update: Long Term Safety and Efficacy Study of Tanezumab in Japanese Adult Subjects With Chronic Low Back Pain [Phase 3]
Summary
A Phase 3 long-term safety and efficacy study of tanezumab in Japanese adults with chronic low back pain has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED | Results posted: 2020-08-11